4.7 Review

Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China

Journal

ACTA PHARMACOLOGICA SINICA
Volume 42, Issue 8, Pages 1212-1222

Publisher

NATURE PUBL GROUP
DOI: 10.1038/s41401-020-00553-9

Keywords

herb-induced liver injury; hepatic sinusoidal obstruction syndrome; pyrrolizidine alkaloids; Tu-San-Qi; Gynura japonica

Funding

  1. Research Grant Council of Hong Kong (GRF) [14111816, 14106318]
  2. CUHK Project Impact Enhancement Fund (PIEF) [3133029]
  3. CUHK Direct Grant [4054503]

Ask authors/readers for more resources

Herbs and dietary supplement-induced liver injury, particularly from the PA-producing herb Gynura japonica, is a major concern in China, often leading to hepatic sinusoidal obstruction syndrome. With over 50% of HSOS cases caused by G. japonica intake, the review provides comprehensive information on distinguishing different plant species and clinical manifestations, aiming to improve public awareness and clinical management of this severe HILI.
Herbs and dietary supplement-induced liver injury (HILI) is the leading cause of drug-induced liver injury in China. Among different hepatotoxic herbs, the pyrrolizidine alkaloid (PA)-producing herb Gynura japonica contributes significantly to HILI by inducing hepatic sinusoidal obstruction syndrome (HSOS), a liver disorder characterized by hepatomegaly, hyperbilirubinemia, and ascites. In China, G. japonica has been used as one of the plant species for Tu-San-Qi and is often misused with non-PA-producing Tu-San-Qi (Sedum aizoon) or even San-Qi (Panax notoginseng) for self-medication. It has been reported that over 50% of HSOS cases are caused by the intake of PA-producing G. japonica. In this review, we provide comprehensive information to distinguish these Tu-San-Qi-related herbal plant species in terms of plant/medicinal part morphologies, medicinal indications, and chemical profiles. Approximately 2156 Tu-San-Qi-associated HSOS cases reported in China from 1980 to 2019 are systematically reviewed in terms of their clinical manifestation, diagnostic workups, therapeutic interventions, and outcomes. In addition, based on the application of our developed mechanism-based biomarker of PA exposure, our clinical findings on the definitive diagnosis of 58 PA-producing Tu-San-Qi-induced HSOS patients are also elaborated. Therefore, this review article provides the first comprehensive report on 2214 PA-producing Tu-San-Qi (G. japonica)-induced HSOS cases in China, and the information presented will improve public awareness of the significant incidence of PA-producing Tu-San-Qi (G. japonica)-induced HSOS and facilitate future prevention and better clinical management of this severe HILI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available